Development of isourea-based covalent GPX4 inhibitors and structure–activity relationship analysis in ferroptosis induction
Year: 2026
Type: article
Abstract: N]-HSQC measurements support enhanced GPX4-ligand interaction under dodecylphosphocholine (DPC) membrane-mimetic conditions. Beyond defining the medicinal-chemistry characteristics of this isourea compound series, our work establishes non-retained leaving-group engineering as a strategy for developing covalent GPX4 inhibitors with tunable cellular and pharmacokinetic properties.
Source: RSC Chemical Biology
DOI: 10.1039/d6cb00321d
Authors: Yang Lu, Zijian Pan, Lijie Bai, Senhao Xiao, Xin Gu, Jiayu Li, Weihua Shi, Xiaoxiao Zhang, Shi’en Liu, Chong Lu, Zhou Zhou, Rongsheng Ma, Yingqiang Xu, Qianli Tan, Hong’e Qu, Die Hu, Bolin Liu, Lili Fan, Hongqing Yao, Zhiwen Chen, Weiwei Fan, Qiwen Qian, Jun Cao, Wu Hou, Qiu Li, Caiyi Wei, Wenqin Zeng, Nathchar Naowarojna, Jun Yu, Yikai Wang, Yilong Zou
Institutions: Fudan University, Westlake University
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,962
OpenAlex ID: W7225916458
